Molecular characteristics of bronchioloalveolar carcinoma and adenocarcinoma, bronchioloalveolar carcinoma subtype, predict response to erlotinib.

Miller VA, Riely GJ, Zakowski MF, Li AR, Patel JD, Heelan RT, Kris MG, Sandler AB, Carbone DP, Tsao A, Herbst RS, Heller G, Ladanyi M, Pao W, Johnson DH
J Clin Oncol. 2008 26 (9): 1472-8

PMID: 18349398 · DOI:10.1200/JCO.2007.13.0062

MeSH Terms (24)

Adenocarcinoma Adenocarcinoma, Bronchiolo-Alveolar Adult Aged Aged, 80 and over Antineoplastic Agents Biomarkers, Tumor Disease-Free Survival ErbB Receptors Erlotinib Hydrochloride Female Humans Immunohistochemistry Lung Neoplasms Male Middle Aged Mutation Protein Kinase Inhibitors Proto-Oncogene Proteins Proto-Oncogene Proteins p21(ras) Quinazolines ras Proteins Suppressor of Cytokine Signaling Proteins Treatment Outcome

Connections (1)

This publication is referenced by other Labnodes entities: